We were delighted to attend the Annual Meeting of the GTA; Current Regulatory and Scientific Issues in Genetic Toxicology, at the University of Delaware! Taking place from 3rd to 5th May, this meeting offered an opportunity for scientists from different types of organizations to exchange knowledge, ideas, views and insights concerning the science of genetic […]
Annual Genetic Toxicology Association Meeting Read More »
Held in Nashville, Tennessee, the SOT 62nd Annual Meeting and ToxExpo featured an array of scientific sessions, posters and presentations. A team of us from Lhasa attended the event, where we hosted two exhibitor-hosted sessions: Tackling ICH S1B using AOPs Supporting drug development using in silico solutions Lhasa Limited scientific posters, in date order. Poster Title: Mechanisms
Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo Read More »
We were delighted to attend the IPEC Excipients Forum 2023. Lhasa Limited Principal Application Scientist, Grace Kocks presented on the Elemental Impurities Data Sharing Initiative. Held in Lisbon, the IPEC Excipients forum brings together experts on pharmaceutical excipients from across the world.
IPEC Excipients Forum 2023 Read More »
We were delighted to attend the 7th Impurities: Genotoxic, Nitrosamine & Beyond summit in Milan, Italy. In addition to focusing on N-nitrosamines, this event explored detecting and reporting genotoxic impurities, as well as recent advances, further development and future considerations towards the different types of impurities present in drugs. Lhasa Principal Scientist, Michael Burns presented
7th Impurities: Genotoxic, Nitrosamine & Beyond Summit Read More »
We were excited to attend the 11th International Drug Chemistry Congress! Held at the Antalya-Kemer Mirage Park Resort Hotel from March 9th – 12th, this Congress was helpful for all participants in pharmaceutical R&D and production, as well as the international pharmaceutical industry. Principal Application Scientist, Fernanda Waechter presented on nitrosamines and the Complex Nitrosamines data
The 11th International Drug Chemistry Congress Read More »
We recently held our first webinar of 2023, ‘Supporting mutagenic impurity and degradant risk assessment using an in silico approach’. This free-to-attend webinar featured talks from Dr. Andreas Broehl, Laboratory Head at Bayer Pharmaceuticals, and Lhasa Limited Senior Scientist, Dr. Ash Ali. In this exciting virtual event, we explored how our in silico software solution Zeneth, can
Supporting mutagenic impurity and degradant risk assessment using an in silico approach Read More »
We were excited to attend USP’s Workshop on Nitrosamine Impurities, organised by United States Pharmacopeia (USP) in collaboration with Indian Pharmaceutical Alliance (IPA). Lhasa Principal Scientist, David Ponting presented within the Toxicity Assessment session, his presentation was titled ‘Application of in silico tools (QSAR) to predict toxicity’.
United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities Read More »
We were excited to attend the Genotoxic Impurities in Pharmaceutical Industry Hybrid Conference! Held in Barcelona, Spain on the 26th and 27th of January and online, the Genotoxic Impurities in Pharmaceutical Industry conference contained case studies from large and small pharmaceutical companies. Discover the latest technical insights and discuss rapidly advancing technologies in Toxicology &
Genotoxic Impurities in Pharmaceutical Industry Read More »
Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
Tel: +44 (0)113 394 6020
© 2025 Lhasa Limited, All rights reserved | Company registration number: 01765239 |
VAT number: 396 8737 77 | Registered charity number: 290866 | Governing documents